{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T09:42:27Z","timestamp":1792057347679,"version":"4.4.0"},"reference-count":22,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,1,3]],"date-time":"2021-01-03T00:00:00Z","timestamp":1609632000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2021,1,3]],"date-time":"2021-01-03T00:00:00Z","timestamp":1609632000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Breast Cancer Res Treat"],"published-print":{"date-parts":[[2021,5]]},"DOI":"10.1007\/s10549-020-06046-x","type":"journal-article","created":{"date-parts":[[2021,1,3]],"date-time":"2021-01-03T12:02:46Z","timestamp":1609675366000},"page":"207-213","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["Identification of factors that influence the decision to take chemoprevention in patients with a significant family history of breast cancer: results from a patient questionnaire survey"],"prefix":"10.1007","volume":"187","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4465-1414","authenticated-orcid":false,"given":"Stacey","family":"Jones","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brian","family":"Hogan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kirtida","family":"Patel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shiwei","family":"Ooi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philip","family":"Turton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rajgopal","family":"Achuthan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Baek","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,1,3]]},"reference":[{"key":"6046_CR1","unstructured":"https:\/\/www.bcrf.org\/breast-cancer-statistics-and-resources#:~:text=Breast%20cancer%20is%20the%20most%20frequently%20diagnosed%20cancer ihibm"},{"issue":"3","key":"6046_CR2","doi-asserted-by":"publisher","first-page":"211","DOI":"10.3122\/jabfm.18.3.211","volume":"18","author":"MM Eberl","year":"2005","unstructured":"Eberl MM, Sunga AY, Farrell CD, Mahoney MC (2005) Patients with a family history of cancer: identification and management. J Am Board Fam Pract 18(3):211\u2013217","journal-title":"J Am Board Fam Pract"},{"key":"6046_CR3","unstructured":"https:\/\/www.nice.org.uk\/guidance\/CG164"},{"issue":"22","key":"6046_CR4","doi-asserted-by":"publisher","first-page":"1652","DOI":"10.1093\/jnci\/dji372","volume":"97","author":"B Fisher","year":"2005","unstructured":"Fisher B, Costantino JP, Wickerham DL, Cecchini RS, Cronin WM, Robidoux A, Bevers TB, Kavanah MT, Atkins JN, Margolese RG et al (2005) Tamoxifen for the prevention of breast cancer: current status of the National Surgical Adjuvant Breast and bowel project P-1 study. J Natl Cancer Inst 97(22):1652\u20131662","journal-title":"J Natl Cancer Inst"},{"issue":"1","key":"6046_CR5","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1016\/S1470-2045(14)71171-4","volume":"16","author":"J Cuzick","year":"2015","unstructured":"Cuzick J, Sestak I, Cawthorn S, Hamed H, Holli K, Howell A, Forbes JF, Investigators I-I (2015) Tamoxifen for prevention of breast cancer: extended long-term follow-up of the IBIS-I breast cancer prevention trial. Lancet Oncol 16(1):67\u201375","journal-title":"Lancet Oncol"},{"issue":"9922","key":"6046_CR6","doi-asserted-by":"publisher","first-page":"1041","DOI":"10.1016\/S0140-6736(13)62292-8","volume":"383","author":"J Cuzick","year":"2014","unstructured":"Cuzick J, Sestak I, Forbes JF, Dowsett M, Knox J, Cawthorn S, Saunders C, Roche N, Mansel RE, von Minckwitz G et al (2014) Anastrozole for prevention of breast cancer in high-risk postmenopausal women (IBIS-II): an international, double-blind, randomised placebo-controlled trial. Lancet 383(9922):1041\u20131048","journal-title":"Lancet"},{"key":"6046_CR7","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1038\/s41523-017-0021-y","volume":"3","author":"KD Crew","year":"2017","unstructured":"Crew KD, Albain KS, Hershman DL, Unger JM, Lo SS (2017) How do we increase uptake of tamoxifen and other anti-estrogens for breast cancer prevention? NPJ Breast Cancer 3:20","journal-title":"NPJ Breast Cancer"},{"issue":"4","key":"6046_CR8","doi-asserted-by":"publisher","first-page":"575","DOI":"10.1093\/annonc\/mdv590","volume":"27","author":"SG Smith","year":"2016","unstructured":"Smith SG, Sestak I, Forster A, Partridge A, Side L, Wolf MS, Horne R, Wardle J, Cuzick J (2016) Factors affecting uptake and adherence to breast cancer chemoprevention: a systematic review and meta-analysis. Ann Oncol Off J Eur Soc Med Oncol ESMO 27(4):575\u2013590","journal-title":"Ann Oncol Off J Eur Soc Med Oncol ESMO"},{"issue":"24","key":"6046_CR9","doi-asserted-by":"publisher","first-page":"4951","DOI":"10.1200\/JCO.2004.05.192","volume":"22","author":"SL Bober","year":"2004","unstructured":"Bober SL, Hoke LA, Duda RB, Regan MM, Tung NM (2004) Decision-making about tamoxifen in women at high risk for breast cancer: clinical and psychological factors. J Clin Oncol 22(24):4951\u20134957","journal-title":"J Clin Oncol"},{"issue":"5","key":"6046_CR10","doi-asserted-by":"publisher","first-page":"375","DOI":"10.1016\/j.cdp.2007.08.003","volume":"31","author":"SA Sabatino","year":"2007","unstructured":"Sabatino SA, McCarthy EP, Phillips RS, Burns RB (2007) Breast cancer risk assessment and management in primary care: provider attitudes, practices, and barriers. Cancer Detect Prev 31(5):375\u2013383","journal-title":"Cancer Detect Prev"},{"issue":"1","key":"6046_CR11","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1016\/j.ypmed.2004.09.041","volume":"41","author":"CP Kaplan","year":"2005","unstructured":"Kaplan CP, Haas JS, Perez-Stable EJ, Des Jarlais G, Gregorich SE (2005) Factors affecting breast cancer risk reduction practices among California physicians. Prev Med 41(1):7\u201315","journal-title":"Prev Med"},{"issue":"Suppl 1","key":"6046_CR12","doi-asserted-by":"publisher","first-page":"S33","DOI":"10.1111\/j.1524-4741.2009.00825.x","volume":"15","author":"J Mulsow","year":"2009","unstructured":"Mulsow J, Lee J, Dempsey C, Rothwell J, Geraghty JG (2009) Establishing a family risk assessment clinic for breast cancer. Breast J 15(Suppl 1):S33\u2013S38","journal-title":"Breast J"},{"issue":"10","key":"6046_CR13","doi-asserted-by":"publisher","first-page":"2352","DOI":"10.1002\/ijc.28875","volume":"135","author":"K Kast","year":"2014","unstructured":"Kast K, Schmutzler RK, Rhiem K, Kiechle M, Fischer C, Niederacher D, Arnold N, Grimm T, Speiser D, Schlegelberger B et al (2014) Validation of the Manchester scoring system for predicting BRCA1\/2 mutations in 9,390 families suspected of having hereditary breast and ovarian cancer. Int j cancer J int du cancer 135(10):2352\u20132361","journal-title":"Int j cancer J int du cancer"},{"key":"6046_CR14","first-page":"624","volume":"52","author":"R Heisey","year":"2006","unstructured":"Heisey R, Pimlott N, Clemons M, Cummings S, Drummond N (2006) Women's views on chemoprevention of breast cancer: qualitative study. Can Fam Physician 52:624\u2013625","journal-title":"Can Fam Physician"},{"issue":"18","key":"6046_CR15","doi-asserted-by":"publisher","first-page":"1371","DOI":"10.1093\/jnci\/90.18.1371","volume":"90","author":"B Fisher","year":"1998","unstructured":"Fisher B, Costantino JP, Wickerham DL, Redmond CK, Kavanah M, Cronin WM, Vogel V, Robidoux A, Dimitrov N, Atkins J et al (1998) Tamoxifen for prevention of breast cancer: report of the National Surgical Adjuvant Breast and bowel project P-1 study. J Natl Cancer Inst 90(18):1371\u20131388","journal-title":"J Natl Cancer Inst"},{"issue":"4","key":"6046_CR16","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1093\/jnci\/djk050","volume":"99","author":"TJ Powles","year":"2007","unstructured":"Powles TJ, Ashley S, Tidy A, Smith IE, Dowsett M (2007) Twenty-year follow-up of the Royal Marsden randomized, double-blinded tamoxifen breast cancer prevention trial. J Natl Cancer Inst 99(4):283\u2013290","journal-title":"J Natl Cancer Inst"},{"issue":"4","key":"6046_CR17","doi-asserted-by":"publisher","first-page":"272","DOI":"10.1093\/jnci\/djk049","volume":"99","author":"J Cuzick","year":"2007","unstructured":"Cuzick J, Forbes JF, Sestak I, Cawthorn S, Hamed H, Holli K, Howell A (2007) International breast Cancer intervention study II: long-term results of tamoxifen prophylaxis for breast cancer--96-month follow-up of the randomized IBIS-I trial. J Natl Cancer Inst 99(4):272\u2013282","journal-title":"J Natl Cancer Inst"},{"issue":"23","key":"6046_CR18","doi-asserted-by":"publisher","first-page":"1751","DOI":"10.1093\/jnci\/djh319","volume":"96","author":"S Martino","year":"2004","unstructured":"Martino S, Cauley JA, Barrett-Connor E, Powles TJ, Mershon J, Disch D, Secrest RJ, Cummings SR, Investigators C (2004) Continuing outcomes relevant to Evista: breast cancer incidence in postmenopausal osteoporotic women in a randomized trial of raloxifene. J Natl Cancer Inst 96(23):1751\u20131761","journal-title":"J Natl Cancer Inst"},{"issue":"1","key":"6046_CR19","doi-asserted-by":"publisher","first-page":"354","DOI":"10.1093\/jnci\/dju354","volume":"107","author":"HB Nichols","year":"2015","unstructured":"Nichols HB, DeRoo LA, Scharf DR, Sandler DP (2015) Risk-benefit profiles of women using tamoxifen for chemoprevention. J Natl Cancer Inst 107(1):354","journal-title":"J Natl Cancer Inst"},{"key":"6046_CR20","unstructured":"https:\/\/www.facingourrisk.org\/index.php"},{"key":"6046_CR21","unstructured":"https:\/\/www.cancerresearchuk.org\/about-cancer\/breast-cancer\/risks-causes\/family-history-and-inherited-genes"},{"issue":"3","key":"6046_CR22","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1023\/A:1025624221369","volume":"6","author":"N Hallowell","year":"1997","unstructured":"Hallowell N, Statham H, Murton F, Green J (1997) Richards M: \u201ctalking about chance\u201d: the presentation of risk information during genetic counseling for breast and ovarian Cancer. J Genet Couns 6(3):269\u2013286","journal-title":"J Genet Couns"}],"container-title":["Breast Cancer Research and Treatment"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10549-020-06046-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10549-020-06046-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10549-020-06046-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,4,22]],"date-time":"2021-04-22T18:29:25Z","timestamp":1619116165000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10549-020-06046-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,1,3]]},"references-count":22,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,5]]}},"alternative-id":["6046"],"URL":"https:\/\/doi.org\/10.1007\/s10549-020-06046-x","relation":{},"ISSN":["0167-6806","1573-7217"],"issn-type":[{"value":"0167-6806","type":"print"},{"value":"1573-7217","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,1,3]]},"assertion":[{"value":"21 October 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 December 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 January 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors have no conflicts of interests\/ competing interests to disclose.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}